The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.30
Bid: 3.20
Ask: 3.40
Change: 0.00 (0.00%)
Spread: 0.20 (6.25%)
Open: 3.30
High: 3.30
Low: 3.30
Prev. Close: 3.30
OGN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

15 Feb 2024 07:00

RNS Number : 1921D
Origin Enterprises Plc
15 February 2024
 

Origin Enterprises plc

 

Transaction in own shares

 

15 February 2024

 

 

Origin Enterprises plc (the "Company") announces that on 14 February 2024 it purchased a total of 12,500 of its ordinary shares of EUR 0.01 each (the "ordinary shares") on Euronext Dublin through Goodbody Stockbrokers UC ("Goodbody"), as detailed below. 

 

Euronext Dublin

 

Number of ordinary shares purchased

12,500

Highest price paid (per ordinary share)

?3.3900

Lowest price paid (per ordinary share)

?3.3000

Volume weighted average price paid (per ordinary share)

?3.3604

 

Following settlement of the above transactions, the Company's total number of ordinary shares in issue (excluding treasury shares) shall be 110,909,406 (each carrying the right to one vote) and the Company's total number of ordinary shares in treasury (which do not carry voting rights) shall be 14,410,969.

 

The repurchased ordinary shares will be held in treasury pending their cancellation or re-issue in due course. The purchases form part of the Company's ?20m share buyback programme announced on 20 November 2023.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (also in force in the UK, from time to time, including, where relevant, pursuant to the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made by Goodbody on behalf of the Company as part of the share buyback programme is set out in the Appendix to this announcement.

 

Contact:

 

Barbara Keane

Group Company Secretary

Tel: +353 1 563 4900

Appendix

Transaction Details

 

Issuer Name

Origin Enterprises plc

LEI

213800AIB4U7N5BLS350

ISIN

IE00B1WV4493

Intermediary Name

Goodbody Stockbrokers UC

Intermediary Code

GDBSIE21XXX

Timezone

GMT

Currency

EUR

 

Euronext Dublin

 

Number of Shares

Price per Share (EUR)

Trading venue

Time of transaction

Transaction Reference Number

716

3.3800

XDUB

09:12:50

00028590267TRDU1

29

3.3800

XDUB

09:12:50

00028590268TRDU1

697

3.3800

XDUB

09:47:24

00028590440TRDU1

1745

3.3600

XDUB

10:00:18

00028590508TRDU1

1145

3.3500

XDUB

12:04:15

00028591116TRDU1

474

3.3500

XDUB

12:08:20

00028591125TRDU1

611

3.3000

XDUB

13:35:44

00028591696TRDU1

736

3.3600

XDUB

13:57:21

00028591948TRDU1

393

3.3600

XDUB

14:26:38

00028592126TRDU1

342

3.3550

XDUB

14:26:38

00028592125TRDU1

43

3.3600

XDUB

14:42:37

00028592199TRDU1

704

3.3600

XDUB

14:42:37

00028592200TRDU1

762

3.3900

XDUB

14:59:27

00028592333TRDU1

1692

3.3650

XDUB

14:59:42

00028592335TRDU1

759

3.3650

XDUB

15:27:50

00028592564TRDU1

770

3.3600

XDUB

15:58:40

00028592924TRDU1

622

3.3550

XDUB

16:19:58

00028593250TRDU1

260

3.3550

XDUB

16:19:58

00028593251TRDU1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSFUFALELSEDE
Date   Source Headline
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20242:34 pmRNSHolding(s) in Company
18th Apr 20247:00 amRNSAppointment of new Joint Corporate Broker
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSAppointment of Group Chief Financial Officer
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20245:43 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20249:56 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20244:12 pmRNSHolding(s) in Company
19th Mar 20244:09 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20243:20 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
11th Mar 20243:00 pmRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20242:00 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20241:23 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSInterim Results Statement
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.